期刊
NATURE REVIEWS CANCER
卷 4, 期 5, 页码 349-360出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrc1361
关键词
-
类别
The proteasome is an abundant multi-enzyme complex that provides the main pathway for degradation of intracellular proteins in eukaryotic cells. As such, it controls the levels of proteins that are important for cell-cycle progression and apoptosis in normal and malignant cells; for example, cyclins, caspases, BCL2 and nuclear factor of kappaB. A proteasome inhibitor bortezomib - has been developed that has shown efficacy as an anticancer agent in the clinic. How can targeting such a universal, broadly active cellular component provide the selectivity and specificity that are required for cancer therapeutics?
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据